BJH - volume 10, issue 7, november 2019
M. Vercruyssen , A. Van den Broeke , A. Salaroli , P. Nguyen , A. De Wind , N. Meuleman MD, PhD, D. Bron MD, PhD
Human T-cell leukaemia virus type 1 (HTLV-1) was the first human oncogenic virus discovered. It is endemic in some regions of the world but increasingly prevalent in our countries as globalisation is progressing. After several decades of asymptomatic carrying, approximately 2–5% of infected individuals will develop adult-T-cell leukaemia-lymphoma (ATL). Despite significant progress in the physiopathology and therapeutic interventions, the prognosis of this rare disease is dismal. An update of classification, clinical features, diagnosis and recent treatment recommendations is outlined in this review.
(BELG J HEMATOL 2019;10(7):277–84)
Read moreBJH - 2018, issue Abstract Book BHS, february 2018
A. Salaroli , D. Bron MD, PhD, M. Paesmans , B. Cantinieaux , P. Heimann MD, PhD, P. Lewalle MD, PhD, S. Wittnebel MD, PhD
BJH - 2018, issue Abstract Book BHS, february 2018
S. Dubruille PhD, C. Kenis , Y. Libert PhD, M. Delforge MD, PhD, L. Dal Lago , M. Roos , C. Borghgraef , A. Salaroli , M. Maerevoet MD, D. Razavi MD, PhD, H. Wildiers , D. Bron MD, PhD
BJH - 2018, issue Abstract Book BHS, february 2018
M. Maerevoet MD, P. Lewalle MD, PhD, N. Meuleman MD, PhD, C. Spilleboudt , A. Salaroli , S. Wittnebel MD, PhD
BJH - volume 8, issue Abstract Book BHS, february 2017
D. Bron MD, PhD, A. Salaroli , N. Meuleman MD, PhD, M. Maerevoet MD, M. Vercruyssen , C. Spilleboudt , A. De Wind , G. Dapri , G.B. Cadiere , B. Cadiere
Top
